Kesios Therapeutics' Series A Round

Kesios Therapeutics raised a round of funding on December 02, 2015.

Kesios Therapeutics is developing novel therapeutics for the treatment of multiple myeloma and other cancers. KES-0001, the company's lead drug candidate, is about to enter clinical studies as a poten…

Articles about Kesios Therapeutics' Series A Round: